Key result
Angiopoietin-like proteins (ANGPTLs) regulate acute and chronic inflammation and are emerging as potential biomarkers and pharmacological targets for inflammatory diseases.
Why the study?
Understanding the emerging roles and mechanisms of angiopoietin-like proteins in acute and chronic inflammation may aid drug and therapy development.
Design
Review
Authors
Loading...
ANGPTLs merit targeted investigation as inflammation biomarkers and therapeutic candidates in CVD; leaves open clinical utility pending prospective trials.
This review highlights the emerging role of angiopoietin-like proteins in inflammation, suggesting they may serve as both biomarkers and therapeutic targets for inflammatory and cardiovascular diseases.
Yang et al. (2021) conducted a review in Inflammation and inflammatory diseases. Angiopoietin-like proteins (ANGPTLs) was evaluated. Angiopoietin-like proteins (ANGPTLs) regulate acute and chronic inflammation and are emerging as potential biomarkers and pharmacological targets for inflammatory diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: